Clinical development of viral vectored vaccines against MERS-COV

Ítems similars

• ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
  per: Alharbi, N, et al.
  Publicat: (2017)
• Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
  per: Munster, V, et al.
  Publicat: (2017)
• Clinical advances in viral-vectored influenza vaccines
  per: Sebastian, S, et al.
  Publicat: (2018)
• Viral vector vaccines
  per: McCann, N, et al.
  Publicat: (2022)
• Viral vectors as vaccine platforms: from immunogenicity to impact
  per: Ewer (nee Russell), K, et al.
  Publicat: (2016)